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Abstract 
Background:  Prescription compliance is a complex issue, affected by physical, 
psychological, and emotional factors.  Changes in color vision due to the normal aging 
process are an aspect of declining physical functioning that has not been addressed in 
relation to prescription compliance. 
Objective: To establish a relationship between medication selection and color vision loss 
in older adults. 
Methods:  This study with healthy younger adults, age 18-26, used a pair of yellow-lens 
glasses and colored beads to simulate medication selection in older adults compared with 
a control group of similarly aged adults not wearing the lenses.  Medication selection was 
quantified by correct bead selection and complexity of challenge was determined by a 
difficulty rating.   
Results:  Participants with the yellow-lens glasses were only able to select the correct 
color of bead 74.4% of the time compared to 100% for the control group.  The 
experimental group also expressed more difficulty with the task giving it a difficulty 
rating of 4.02 out of 5 compared to 1.04 out of 5 in the control group.   
Conclusions: This study concluded that older persons were more likely to have difficulty 
selecting their medications based on color which has implications for non-compliance. 
They are also more likely to experience frustration with their medication therapy due to 
color vision changes.   
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Aging has been the center of new research in many areas.  Understanding the 
aging process can help society in many ways.  With the growing population of older 
adults it is going to become even more important to understand the changes that occur 
with age.  Senescence affects the body in many ways, taking its toll on all organ systems.  
The sensory organs are no exception; there have been several findings in regards to the 
aging and senescence of the senses, most notably vision.  As with all organ systems, the 
visual system shows an increased risk of failure with increased age.1    Most people 
associate vision changes only with acuity, contrast sensitivity, and visual field, which are 
the functions that are most associated with everyday functioning.  One visual function is 
often overlooked, especially by healthcare practitioners, color vision and perception.  
Although color vision seems to many to be an insignificant change, this loss can actually 
cause more problems than realized before.  Many understand that changes in vision are 
important to everyday functioning, but few understand the problems and frustrations that 
might occur with declines or loss of color vision.  The concept of color vision is easily 
neglected as a practitioner, but this failure of acknowledgement can potentially lead to 
frustrations for older adults and ultimately misunderstandings between patient and 
clinician.  Even with additional education in aging, it is quite easy to forget the 
disabilities of older adults in everyday situations.  Improving healthcare for older adults 
presents a multitude of problems, many of these problems can be overcome with 
knowledge and understanding of this population.2   
One of the largest problems facing healthcare and older adults is prescription non-
compliance.  Compliance is defined as taking the right drug, right dose, at the right time.  
As the population ages, there is an increased incidence of chronic disease, many older 
adults having one or more.  With the increased morbidity of older adults there is an 
increased use of prescription, as well as over the counter medications.  It has been found 
that the use of prescription medications can greatly improve quality of life and even 
increase one’s life span.  The benefits have been proven time and time again, but there 
still seems to be a vast problem with prescription compliance for various reasons.3   Most 
older adults have noticeable impairment in everyday tasks, situations, and settings.4   
These impairments are due to a large number of problems with bodily function, but 
vision has been shown to be one of the key factors in maintaining independence into old 
age.  Despite this correlation little research has been done on the association of 
prescription compliance to vision, let alone color vision.1  
The small amount of research available established that there is a direct 
correlation between physical performance and several visual functions.  Having a poor 
performance on vision function tests were correlated with self-reports and objective 
observations of difficulties in physical functioning.1   Special note should be made that 
even those with relatively good vision report having difficulties with vision under 
everyday conditions, giving rise to concerns that general vision tests are not useful in 
determining vision function in older adults.4   These observations are no different for 
prescription compliance.  Vision, most importantly that for color, is used for 
organizational and memory cues, two functions needed for compliance.  Color contrast 
sensitivity and discrimination ability is important in distinguishing between tablets or 
capsules of similar color, size, and/or shape.5   Beyond this, the visual appearance of oral 
dosage forms is related to a patient’s acceptance and compliance.  If a patient does not 
like the appearance of a specific drug they are less likely to take it as directed.  
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Researchers have also found that patients associate specific colors to a drug’s therapeutic 
function and strength.  Some believe dosing medication in this manner would be 
beneficial allowing patients to more readily remember which medication is for which 
condition.6   If pharmacists and physicians understand color vision changes, they will be 
more prepared to assist patients in developing a memory system in regards to color for 
their drug regimen.  Without knowledge of color vision changes, attempts at assistance 
can cause frustration and miscommunication.   
Besides color associations, color popularity can also affect the perception of a 
specific drug form.  Researchers observed that those taking more than ten solid oral 
dosage form medications preferred bright colors, despite the overall popularity of white.6   
This observation is assumed to be related to the previous discussion on the relationship of 
color and memory.  The more medications a person takes the more effort is needed to 
take them properly.  Memory cues can be very useful in compliance, so it seems that 
those taking several medications would like each drug to be a different color as research 
has shown.  Since a majority of older adults take multiple medications it is important to 
study the effects of color on the older population.  While research does present significant 
data on color preferences, most fail to effectively take into account the changes in color 
vision seen in older adults.7   
Given the wide variety of colors within pharmaceuticals and the high percentage 
of prescription sales being to older adults, one might assume developers would take into 
consideration the color vision changes that occur with age.8  To the contrary, 
pharmaceutical companies appear to generalize findings on color vision perception as 
being associated with all age groups.  Though still behind in acknowledging the many 
changes that come with age, the pharmaceutical industry has made strides to increase 
compliance.  Along with these advances, healthcare practitioners must still be aware of 
the frustrations that color vision changes might cause.  Since these changes occur 
gradually, it may take several years for one to notice them, if at all.  With this knowledge, 
healthcare practitioners can more readily treat patients for a better health outcome.   
Color vision expresses a variety of changes throughout one’s lifetime.  Overall, 
each aspect of color vision has been shown to decline significantly with age although at 
different rates and beginning at different times in one’s life history.  Color contrast 
sensitivity decreases significantly, giving rise to a lower sensitivity for color differences 
in older persons.9  In low light, the differences between older and younger adults are 
greater than in high light.  Essentially all ages experience the same contrast sensitivity on 
different spatial scales.10   Colorimetric purity also decreases linearly with age, which 
results in the inability to distinguish between white and colors with low purity such as 
pastels, and can make colors of all saturations look dull.11, 12  Low light adds to the 
challenge an older adult has in making a distinction between two similar colors; by 
increasing the amount of light, this difficulty decreases slightly.  As established the most 
noticeable change in color vision is the inability to distinguish or even detect certain 
colors.13, 14   
Changes in color vision manifest themselves in several ways, but are caused by 
similar mechanisms.  The largest component causing color vision change is the 
senescence of the lens.  As humans age the lens grows thicker, denser, and more 
spherical, reducing the radius of curvature.  Changing the shape and curvature of the lens 
directly reduces refraction and the increased material modifies the refractive index.15  
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Although changes in refraction are important, they are only minor in relation to color 
vision.  Refraction affects the amount of light reaching the retina, thus decreases in 
refraction cause a reduction in the amount of stimuli reaching the proper photoreceptors.    
Lenticular yellowing exponentially increases the absorbance of light passing through the 
lens.  The greatest absorbance is for wavelengths between 460 and 470nm, which 
correspond to the blue portion of the visible spectrum.  Absorbance appears to primarily 
affect short wavelengths with little variation in absorbance of longer wavelengths.  Older 
persons show a higher reduction in their ability to detect those colors in the blue-violet 
spectrum than in the yellow-red spectrum.15, 16  
In addition to changes in the lens, there are significant changes in 
neurotransmission.  Changes in the neurons and the general structure of cones ultimately 
cause a decrease in the sensitivity of cone pathways.  Research has shown that S-cones 
are more prone to damage than L or M-cones, and therefore the sensitivity of S-cones 
show a greater overall loss.13,17  Besides decreases in cone sensitivity, several other 
modifications to the retina have been shown to cause declines in color vision.  These 
would include decreased cone density, disordered arrangement of cones due to 
photoreceptor loss, as well as loss of nuclei in the outer nuclear layer.18  The 
misalignment of the outer segment membrane can cause shifting in the placement of 
remaining cones and can therefore decrease the amount of light incident on them.19,20   
The sum of these changes results in major declines in color vision that are not usually 
recognized or addressed.   
Generalizations about the entire prescription population based upon studies that 
that do not account for age differences in color vision can cause more problems than 
solutions.  This study explores the difficulties that can be caused by the decreases in color 
vision in older adults.  To the knowledge of the researchers, this is the first and only 
study associating color vision with medication selection.  Specifically, this study used 
simulated age related changes in color vision as well as simulated medication to 
determine an association between color vision and medication selection.  This study 
wishes to establish beyond the documented research that it is necessary to consider color 
vision changes when working with older adults, in addition to determining the extent to 
which prescription compliance might be affected by color vision changes.     
 
Methods 
Participants 
 This study used a total of 60 participants between the ages of 18 and 26.  
Participants were randomly selected and placed into one of two groups, control or 
experimental, 30 participants each.  Eligibility requirements were based upon eye health.  
Researchers wanted to control for color blindness, glaucoma, cataracts, macular 
degeneration, and any other disorders of the eye that could potentially affect color vision.  
Volunteers with these conditions were excluded from the experiment.  Due to the high 
prevalence of eye disorders among older adults, in addition to the increased likelihood 
that these disorders might go unnoticed, researchers chose to simulate age changes to 
avoid these confounding variables.  Based on the results from a power analyses, a sample 
size of 60 was determined adequate to achieve at least a 95% level of confidence in 
difference between control and experimental group.  Since the number of participants 
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was important, recruitment of volunteers continued until 60 eligible participants were 
found. 
 
Procedure 
 Prior to participant recruitment, the Institutional Review Board at the Ohio State 
University reviewed study design and the study was determined to be exempt from 
review by the IRB.  Participants were required to read and sign a standard consent form 
prior to assignment to a group.  A researcher explained the experiment to all participants 
as well as read the consent form aloud before proceeding with the participants’ signature.  
Once consent was received, participants were randomly placed into either the control or 
experimental group.  The only difference between the two groups was that the 
participants in the experimental group were asked to wear a pair of yellow-lens glasses, 
which are routinely used in teaching health practioners about color vision changes in 
older adults (double laminated on 10 pt board with special yellow filters designed to 
simulate illuminance in a 70 year old person).  As proven by several studies, the human 
lens yellows overtime and it was therefore assumed that yellow filters would simulate 
this.  The yellow lenses used in this study are similar to those used in other studies on 
color vision in older adults.  Suzuki, et al as well as, Okajima and Takase concluded that 
the simulated lenses used with younger adults were a valid proxy for studying the effects 
of color vision deficits in older adults.14,21,22  Several studies have also used yellow filters 
as a way of simulating an ages lens and have found similar results.9,21-4  All participants 
were asked several questions pertaining to their eye health prior to performing the 
experiment which determined their eligibility.  After eligibility was determined, 
participants in the experimental group were asked to put on the yellow-lens glasses.   
All participants were given a prescription medicine bottle containing 80 colored 
beads, 10 each of red, orange, yellow, green, blue, purple, white, and brown (round, 
10mm wooden beads colored using ceramcoat acrylic paint).  Participants were asked to 
select a specific number of beads according to color and place them on an ordinary paper 
plate.  The number of beads requested according to color is shown in Table 1.  In each 
step of the experiment, a new color was requested independently from the others, so as to 
evaluate each color separately and without bias.  The experiment for all participants was 
carried out under standard desk lighting in mid-afternoon.  The number correct and the 
colors that were mistaken were recorded.  Each participant was given no time limit in 
which to finish the experiment.  Upon completion, participants were asked several 
questions to further assess their thought processes throughout the experiment in addition 
to the overall difficulty of the experiment.  Participants were asked what colors they 
found to be the most difficult to see and which color pairs were difficult to distinguish 
between.  In addition, participants were asked what led them to choose a specific color 
bead over another, whether there was an aesthetic attribute or if the decision was made by 
guessing.  Finally, participants were asked to rate the difficulty of the task on a scale 
ranging from 1=easy and 5=difficult.   
 
Results 
Measures 
 Scores were calculated as the number of beads that participants correctly selected 
based on the researcher’s instructions to identify an individual color.  Researchers were 
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particularly interested in several color pairs, red and orange, yellow and white, blue and 
green, and purple and brown.  The scores from each individual color were compared 
between control and experimental groups as well as to its paired color in order to find 
relative correlations.  The researcher also considered participants’ responses to the 
researcher’s questions that were asked at the end of the experiment.  These responses 
were important in assessing differences between the control and experimental groups.  
The post-questions explored which colors participants felt were the most difficult to see 
and which color pairs were difficult to distinguish between.  The total number of 
participants that recognized certain colors and color pairs was calculated.  These totals 
were used in comparison with the average number of correct beads selected, particularly 
with the experimental group, in order to establish a relationship between how the 
participant felt about their decision and their actual result.  The responses pertaining to 
the decision-making process were used to determine what other attributes of the beads 
were used to make a selection, which allowed the researchers to draw further conclusions 
on aesthetics and prescription compliance.  The difficulty scores the participants gave the 
experiment were also compared between the two groups to find the relative difficulty 
between the control and the experimental group.   
 
Data Analysis 
 Paired t-tests were used to establish the difference between the scores of the 
experimental group as compared to the control group.  Colors and color pairs that showed 
a p-value <0.05 were considered to show a significant difference between the control and 
experimental group.   
 
Results 
 The number correct provided by each group was compared taking specific note of 
particular color pairs: red/orange, white/yellow, green/blue, and purple/brown, as well as 
taking into account total number of correct beads.  A significant difference (p<0.05) 
between the control and experimental groups were found with all colors, with the 
exception of red and orange, where no significant difference was found.  The control 
group showed no difficulty in distinguishing any of the color pairs, whereas the 
experimental group showed significant difficulty with all pairs with the exception of 
red/orange where no difficulty was shown.  Percentage correct is presented in Figure 1.  
The most significant differences between control and experimental groups were found 
with purple and brown.  The experimental group showed mean scores of .77±0.971 
(25.67%) and 1.87± 1.697(31.17%) respectively.  Participants were more likely to make 
an error when selecting purple over brown with ~5% difference in percentage correct.  
The post-test responses further support the relative difficulty of determining the purple 
beads from the brown.  The highest number of participants in the experimental group, 28 
of 30 participants (93.3%) recognized purple/brown as one of the more challenging pairs 
to distinguish.  In contrast, the best scores, excluding red and orange, were for yellow and 
white, which showed scores of 2.40± 0.855(80.0%) and 5.03± 1.351(83.83%) 
respectively.  Participants were more able to properly select white beads over yellow 
beads with ~3% accuracy difference.  These scores are surprising since 27 of 30 (90.0%) 
participants from the experimental group reported yellow and white as a difficult color 
pair to distinguish between.  The results of the color pair blue and green closely follow 
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those of white and yellow, with scores of 2.37± 0.928(79.0%) and 5.37± 0.928(89.5%) 
respectively.  The participants showed a greater ability to select green over blue, with a 
percentage correct difference of ~10%, showing the greatest difference between scores of 
any color pair.  Only 24 out of 30 participants (80.0%) in the experimental group 
recognized blue/green as a difficult pair.  Totals showed a mean score of 24.80± 
3.284(74.44%), with high variability between subjects.  Table 2 shows standard 
deviation, standard error mean, mean scores, and p values of t-test samples for all color 
pairs.  One participant in the experimental group expressed difficulty in distinguishing 
between green and brown during the post-test.  This participant also showed irregular 
patterns in color selection among purple, brown, blue, and green.  The participant’s 
overall score was 19 correct selections out of the possible 36 (52.78%), where the 
average score was 26.8 (74.44%).   
 Following the experiment, participants in the experimental group were asked to 
comment on their thought processes throughout the experiment, particularly why they 
chose one bead over another.  The most common response was shade; most participants 
reported using the shade of the apparent color to decide which beads belonged together.  
This led many participants to select all the same color beads, but in many cases they 
selected beads of the incorrect color.  Texture was also a frequent method in determining 
the correct beads to select.  Several participants noticed subtle differences in the texture 
of the different colored beads.  It is believed the texture differences were due to the paint 
used on the beads, which caused some beads to have a slightly different texture.  Another 
recurrent response was pure guessing.  Several participants reported guessing in order to 
make the proper selections, for some, this method worked, for others it did not.  
Additionally, all participants were asked to rate on a scale from 1 to 5 the difficulty of the 
task they were asked to perform, 1=easy and 5=difficult.  The average difficulty score for 
the control group was 1.04 and the average score for the experimental group was 4.02.   
 
Table 1. Requested Beads 
Color # Requested 
Red 3 
Orange 6 
Yellow 3 
White 6 
Purple 3 
Brown 6 
Blue 3 
Green 6 
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Table 2. Paired T-Test Samples (n = 30) 
Color Group Mean Scores Std. Deviation Std. Error 
Mean 
p-value 
Experimental 3 .000 .000 Red 
Control 3 .000 .000 
No difference
Experimental 6 .000 .000 Orange 
Control 6 .000 .000 
No difference
Experimental 2.40 .855 .156 Yellow 
Control 3.00 .000 .000 
.001 
Experimental 5.03 1.351 .247 White 
Control 6.00 .000 .000 
.000 
Experimental 0.77 .971 .177 Purple 
Control 3.00 .000 .000 
.000 
Experimental 1.87 1.697 .310 Brown 
Control 6.00 .000 .000 
.000 
Experimental 2.37 .928 .169 Blue 
Control 3.00 .000 .000 
.001 
Experimental 5.37 .928 .169 Green 
Control 6.00 .000 .000 
.001 
Experimental 26.80 3.284 .600 Total 
Control 36.00 .000 .000 
.000 
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Figure 1. Percentage Correct in Experimental Group 
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Discussion 
 The geriatric population accounts for more than half of all prescriptions in the 
United States to date.    For decades, it has been well established that color vision is 
impaired in the older adult population.  This study has shown that impaired color vision 
poses significant challenges to proper medication therapy, especially as it pertains to 
prescription compliance.  Colored beads and yellowed lens glasses were used to simulate 
medication selection under conditions of impaired vision.  There were noteworthy 
differences between participants with and without the yellow lenses in their ability to 
select the correct colored bead.   Those using the yellow lenses were not only more likely 
to make errors, but also showed more frustration and less confidence in their bead 
selection.  This study has reinforced findings from previous research on color vision.  As 
with many other studies, this study has shown that older adults have the most difficulty 
with colors in the blue-violet range of the color spectrum.9,11-18,20,23  As a result we have 
found that specific pairs of colors were less likely to be differentiated than others; most 
notably blue and green, brown and purple, as well as white and yellow.7  All participants 
in the experimental group reported using other visual clues to select the proper beads, 
including texture and shade, which for many failed to assist them in selecting the correct 
color.  Several participants selected beads of the same color, but the incorrect color from 
what was requested.  Some differences in percentage correct could be due to differences 
in number of beads requested.  Participants generally scored higher when asked to select 
a greater number of beads, but the mean difference in error showed larger differences 
between the two groups when a larger number of beads were requested.   
 This study has established a causal relationship between color vision changes in 
older adults and medication selection, which has not been previously explored.  Although 
prescription compliance is a complex issue with many variables, this study has presented 
another possible explanation for compliance difficulty in older adults.  Other studies 
addressed vision changes in older adults, including visual acuity, stereopsis, and contrast 
sensitivity, but these studies did not address deficits in color vision.  Contrast sensitivity 
is closely related to color vision, but cannot be considered as a basis of measurement for 
color vision.  Since the color of prescription drugs is a key component of both marketing 
and counseling of these products, being able to distinguish product color is thought to be 
a key component of compliance. 
 The limitations of this study relate to study conditions and the challenge in the 
generalizability of the findings.  All participants were healthy young adults, presumably 
without color vision disturbances, although their color vision was not tested for the 
purposes of this study.  Researchers decided to exclude older adults from this study due 
to the higher likelihood of having eye disorders, as well as the increased possibility these 
disorders go unnoticed and unaddressed.  The data of this study suggest only one 
participant deviated largely from the median, possibly as the result of undiagnosed color 
blindness.  The experiment was conducted under optimal lighting conditions, but day to 
day variations available in daylight could have made a small impact on the overall 
lighting in the room.  Threats to internal validity were minimized by randomization of 
subjects.  Any generalization of this study’s findings to older adults should be made with 
caution since this study used younger subjects.   
 The original objective of this study was to find a correlation between color-vision 
changes in older adults and their risk for prescription noncompliance due to physical 
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inability.  Several studies have shown that prescription compliance is lower in older 
adults, which has largely been attributed to cognitive impairment.  This study sought to 
prove that even fully cognitive patients may make medication errors due to impaired 
color vision.  This study found that in addition to increases in the likelihood of making an 
error we also found an increase in frustration at the difficulty of selecting the correct 
colored bead.  Participants wearing the lenses expressed less confidence in their selection 
abilities in addition to finding the task more challenging than expected and expressing 
frustration with their inability to make a selection even without knowing if they were 
correct.   
 There are many implications resulting from the selection of the wrong pill from a 
group of medications.  Even given appropriate lighting, an older adult would be more 
likely to select the wrong drug at the wrong time of day therefore missing a dose of one 
drug and interrupting the dosing regimen of another.  For many prescription therapies, 
taking the drug consistently is crucial for successful treatment.  Another implication is the 
increased risk for overdosing if two or more medications are of similar size and shape, 
with color being the only discriminator.  Treatment failure is common in older adults and 
has largely been attributed to non-compliance.25-29   This study has shown that there is a 
strong likelihood for selecting the wrong medication due to color deficiencies in the older 
population.   
 Many drugs are color coded by strength, most commonly warfarin.  All generics 
of this product must match the color of brand Coumadin®.  This system was devised to 
ensure patient safety in both dispensing and in managing a complicated drug regimen.  
There have been many concerns as to whether or not this was a useful tool in preventing 
medication errors.  In 2005, the FDA held a hearing regarding color labeling in which 
presenters expressed concern that there was little efficacy seen in using color coding and 
in fact may be harmful to patients. Several presenters argued that perhaps this might 
make drug regimens more difficult for older adults due to their color vision 
deficiencies.30   This study has shown color vision deficiencies can make a seemingly 
simple task very challenging.  Furthermore, beyond color requirements of warfarin, there 
are many generic brands for the same drug and no regulations require them to be the 
same color as the brand drug.  So for a given drug there can be multiple formulations all 
differing in color therefore minimizing the likelihood that from refill to refill customers 
will get the same color product.  If the drug color is continually changing, using color to 
distinguish between drugs is not entirely feasible.   
On average, adults over the age of 60 use millions of prescription drugs each year, 
making their drug regimens more complicated.  Color is a seemingly easy way for 
healthcare providers to assist their patients with complex dosing regimens.  Although this 
has become a common practice, healthcare providers need to be more aware of the 
potential complications that can occur as a result.  Miscommunications can arise if a 
patient is told their medication is going to be purple, but to them it appears brown.  
Patient’s might feel additional frustration, confusion, and question whether they are 
receiving the correct medication.  A potential solution would be to show patients the 
medications they will be taking as the pharmacist counsels them, without referring to 
color.  This would allow patients to make their own memory cues based on color, shape, 
and texture of the medication.  Not only would miscommunication and confusion be 
minimized, but the patient would be more comfortable and confident in their medication 
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therapy.  To better prepare future healthcare professionals, educators should incorporate 
curricular elements that expose students to the challenges faced by the older populations.  
During therapeutics courses and in practice counseling sessions, it would be beneficial to 
use age sensitivity exercises to help students apply therapeutic topics to the older 
population.   
Healthcare practitioners are not the only group that would benefit from applying 
knowledge of color vision deficits in the older population.  The pharmaceutical industry 
continually employs psychology to decide the color of their drug and many companies 
sponsor their own research into color preferences.  Most of these studies do not include 
many, if any, patients over the age of 65.6-8   Without inclusion of this population these 
results cannot be generalized to this population.  Those studies that have been directed 
toward the geriatric population have found similar results to this study, but are few in 
number.8   Considering these findings, drug companies still advertise with colors that are 
difficult for older adults to see.  In order to best serve older adults, all of their physical 
difficulties should be considered, including color vision.    
 To best apply the results of this study, pharmaceutical companies should consider 
the inclusion of older adults in studies on perception and acceptance of oral dosage 
forms.  Furthermore, it is difficult to fully generalize the results of this study to older 
adults since it only simulated age-related changes, therefore more studies like this should 
be done comparing actual older adults with younger adults.  Future research should also 
be considered to more fully explain the functional implications of color vision loss.  
Continued research should be done to analyze the best ways in which to counsel older 
patients on their drug regimen based upon the results found in this study.   
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